The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Valsartan
Valsartan oral · VALSARTAN 4 mg/mL · Solution · Oral · Advagen Pharma Ltd
NDC 72888-0184-48 · 120 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$275.00
Reported to Texas DSHS · 2026 annual filing · AdvaGen Pharma Limited
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA216460
- TE code
- AB
- Approval date
- Jun 5, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Valsartan oral (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Advagen Pharma Ltd | VALSARTAN 4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Valsartan — NDC 72888-0184-48," retrieved September 3, 2026, https://drugdashboards.com/drug/72888018448.
Free to cite with attribution — see how the data is put together.